GE HealthCare Technologie... (GEHC)
NASDAQ: GEHC
· Real-Time Price · USD
73.39
-0.27 (-0.37%)
At close: Aug 15, 2025, 3:59 PM
73.20
-0.26%
After-hours: Aug 15, 2025, 07:12 PM EDT
GE HealthCare Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.01B | 4.78B | 5.32B | 4.86B | 4.84B | 4.65B | 5.21B | 4.82B | 4.82B | 4.71B | 4.94B | 4.58B | 4.48B | 4.34B | 4.59B | 4.3B | 4.35B | 4.35B |
Cost of Revenue | 3.02B | 2.77B | 3.04B | 2.84B | 2.84B | 2.75B | 3.05B | 2.89B | 2.88B | 2.82B | 3.01B | 2.8B | 2.69B | 2.67B | 2.73B | 2.54B | 2.57B | 2.57B |
Gross Profit | 1.99B | 2.01B | 2.27B | 2.03B | 2B | 1.9B | 2.16B | 1.94B | 1.94B | 1.89B | 1.93B | 1.77B | 1.8B | 1.68B | 1.86B | 1.77B | 1.77B | 1.77B |
Operating Income | 654M | 629M | 801M | 676M | 608M | 540M | 689M | 617M | 570M | 559M | 777M | 605M | 631M | 509M | 727M | 653M | 708M | 708M |
Interest Income | 6M | n/a | n/a | 5M | n/a | n/a | 7M | 6M | n/a | 13M | n/a | 4M | n/a | n/a | 6M | 10M | 2M | 2M |
Pretax Income | 613M | 692M | 834M | 658M | 578M | 512M | 609M | 636M | 570M | 546M | 718M | 622M | 639M | 533M | 755M | 677M | 722M | 722M |
Net Income | 486M | 564M | 720M | 471M | 428M | 374M | 403M | 375M | 418M | 372M | 554M | 488M | 485M | 389M | 564M | 504M | 581M | 581M |
Selling & General & Admin | 1.03B | 1.04B | 1.13B | 1.03B | 1.07B | 1.04B | 1.15B | 996M | 1.07B | 1.06B | 884M | 908M | 908M | 931M | 910M | 914M | 869.5M | 869.5M |
Research & Development | 302M | 344M | 344M | 316M | 327M | 324M | 315M | 322M | 298M | 270M | 271M | 260M | 257M | 238M | 225M | 200M | 195.5M | 195.5M |
Other Expenses | -2M | -1M | n/a | -1M | n/a | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.33B | 1.38B | 1.47B | 1.35B | 1.39B | 1.36B | 1.47B | 1.32B | 1.37B | 1.33B | 1.16B | 1.17B | 1.17B | 1.17B | 1.14B | 1.11B | 1.06B | 1.06B |
Interest Expense | 113M | 111M | 111M | 130M | 131M | 138M | 131M | 138M | 137M | 136M | 60M | 2M | 22M | 6M | 6M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.35B | 4.15B | 4.52B | 4.19B | 4.23B | 4.11B | 4.52B | 4.21B | 4.25B | 4.15B | 4.16B | 3.97B | 3.85B | 3.83B | 3.86B | 3.65B | 3.62B | 3.62B |
Income Tax Expense | 113M | 104M | 96M | 168M | 143M | 124M | 193M | 250M | 137M | 163M | 151M | 129M | 153M | 131M | 179M | 160M | 130.5M | 130.5M |
Shares Outstanding (Basic) | 457M | 457M | 457M | 457M | 457M | 456M | 455M | 455M | 455M | 454M | 453.93M | 454M | 454M | 453.93M | 454.71M | 454.71M | 454.71M | 454.71M |
Shares Outstanding (Diluted) | 458M | 459M | 459M | 459M | 459M | 459M | 458M | 458M | 458M | 457M | 453.93M | 454.71M | 454.71M | 454.71M | 454.71M | 454.71M | 454.71M | 454.71M |
EPS (Basic) | 1.06 | 1.23 | 1.58 | 1.03 | 0.94 | 0.82 | 0.89 | 0.82 | 0.92 | 0.42 | 1.22 | 1.07 | 1.07 | 0.86 | 1.27 | 1.11 | 1.28 | 1.28 |
EPS (Diluted) | 1.06 | 1.23 | 1.57 | 1.02 | 0.93 | 0.81 | 0.88 | 0.82 | 0.91 | 0.41 | 1.22 | 1.07 | 1.07 | 0.86 | 1.27 | 1.11 | 1.28 | 1.28 |
EBITDA | 874M | 939M | 1.08B | 931M | 858M | 798M | 899M | 927M | 848M | 839M | 938M | 767M | 818M | 698M | 915M | 808M | 866M | 866M |
EBIT | 726M | 803M | 945M | 788M | 709M | 650M | 755M | 774M | 692M | 682M | 778M | 607M | 661M | 539M | 761M | 653M | 708M | 708M |
Depreciation & Amortization | 148M | 136M | 140M | 143M | 149M | 148M | 144M | 153M | 156M | 157M | 157M | 160M | 157M | 159M | 154M | 155M | 158M | 158M |